NDC11 59310061031
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 59310-0610-31 | 59310-0610 |
| 59310-610-31 | 59310-610 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CINQAIR | RESLIZUMAB | Teva Respiratory, LLC | 053b9158-2a5b-48b9-bf47-5fa78a35ec33 | 2020-02-29 | Boxed warning, Warnings, Adverse reactions | 59310-610-31 59310-610 59310061031 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.